Regulations
Depositories to get penal powers for discrepancies

While depositories and stock exchanges have already been asked to take necessary actions against defaulting companies, SEBI is of the view that certain regulations need to be amended to empower the depositories to take penal actions in such cases


New Delhi: Market regulator Securities and Exchange Board of India (SEBI) has decided to empower depositories to take penal action against companies that do not properly reconcile their demat and physical shares and thus expose the equity market and investors to possible frauds, reports PTI.

 

The depositories have the mandate to help the companies convert their physical shares into de-materialised or demat form and thereafter maintain those shares, while the companies are required to reconcile their total share capital, including physical and demat shares, in a proper manner.

 

However, discrepancies have come to light in share capital reconciliation of hundreds of the companies, a senior official said.

 

While depositories and stock exchanges have already been asked to take necessary actions against defaulting companies, SEBI is of the view that certain regulations need to be amended to empower the depositories to take penal actions in such cases.

 

A proposal to this effect has been approved by SEBI board and the necessary amendments would be made soon to SEBI (Depositories and Participants) Regulations, the official said.

 

The proposed amendment would allow depositories to take action if a company or its agent contravenes any provision of the relevant regulations and/or fails to furnish any information relating to its activity as an issuer of shares.

 

Besides, SEBI can take action against an issuer that contravenes any of the relevant regulations, fails to provide the information sought from it, does not co-operate in any inspection, investigation or enquiry conducted by any person authorised by SEBI and fails to comply with SEBI directions.

 

For the purpose of enabling issue of demat shares, the issuers enter agreements with the depositories and their agents and these agreements lay down obligations to comply with the provisions of the relevant SEBI regulations.

 

However, it has been observed that there is no provision for action which can be taken by depositories in the event of non-compliance by issuers or their agents.

 

One of the obligations requires proper reconciliation of share capital by the issuer company.

 

"The non-reconciliation of share capital undermines the integrity of the market," SEBI has said in a memorandum presented before its board.

 

"In order to ensure protection of investors and market integrity, there is need to have measures in place to prevent issuer companies/promoters and issuer's agents from introducing fraudulent shares in the market or borrowing against such shares or accessing banking system for loans etc," SEBI said.

 

Under the existing regulations, a company needs to reconcile its share capital on daily basis and send an quarterly audit report to the stock exchanges on reconciliation of the total issued capital, listed capital and capital held by depositories in demat form.

 

In case of discrepancies, the issuer is obligated to bring it to the notice of the exchanges and depositories.

 

One of the challenges observed in the present depositories framework is that in case of some issuers, issued capital or listed capital does not reconcile with the actual capital (demat and physical shares), thereby indicating non-compliance with D&P Regulations.

 

As per reports submitted by the stock exchanges to SEBI, some companies have failed to submit quarterly audit report or have reported discrepancies in share capital reconciliation.

 

Further, in some cases, the discrepancy is explainable whereas in some cases, the issuer is unable to provide justification for the discrepancy.

 

NSE and BSE have reported discrepancies in share capital reconciliation of 329 and 695 companies respectively for the quarter ending March 2012.

 

To curtail the transfer of additional issue of shares by listed companies, SEBI has asked the depositories to devise a mechanism so that such newly created securities are frozen till final listing/trading permission by the exchange.

 

Depositories have also been asked to create a database of distinctive numbers, to be implemented in phases -- first phase by 31 October 2012 and the second by 31 December 2012.

 

In second phase, the issuers and their agents would provide information on listed capital, number of shares in demat and physical form and number of shares pending final approval.

 

The interface of database would be common across both the depositories, exchanges and the companies and would enable all the stakeholders to view the status of shares issued, listed and dematerialised on a common interface.

 

The database would enable all issued shares to be accounted for through their distinctive numbers and would require periodic updating and monitoring by the depositories.

User

COMMENTS

arun adalja

4 years ago

why sebi is asking depositories to do this exercise of reconcilation?sebi can do itself.if someone goes in details big scam will come out.in past many companies issued more shares than equity.what about buyback of shares by the companies?equity must be reduced to that extent is there anyone checking this thing?views are welcome and if anybody has got figures please provide.

Max Bupa Health Assurance: Lifelong personal accident and critical illness

Senior citizens who complained of being excluded from a personal accident and critical illness policy when they really needed now have an option of lifelong renewal 

 
Max Bupa Health Assurance is a product with lifelong renewal, a demand that addresses the core need of senior citizens who were refused renewal of personal accident (PA) policy after age of 70, ostensibly due to increased possibility of accidents at an older age. 
 
Critical illness is another product which excludes customers as early as 50 years; some policies run till age 60 years. Again, critical illness like first heart attack, stroke, paralysis, cancer is likely to strike more after age 60 years—the time when the product is unavailable for customers to cover their risk. Max Bupa Critical Illness cover is a reasonably priced product covering wide range of illnesses with lifelong renewal benefit.
 
At Moneylife foundation event in Kochi last week, Dr A Noble, a retired principal scientist, talked about PA policy not renewed for him after he reached age of 80 years. He had paid premium for years together, but even after being completely fit, the refusal by the insurance company to renew his policy left him angry and frustrated. Case-to-case renewal after 70 years is done at complete discretion of the insurer. Moneylife Foundation had raised the issue of lifelong renewable PA product in the memorandum sent to the Insurance Regulatory and Development Authority (IRDA) in May 2012. Lifelong renewal of a PA policy should be a norm rather than an exception.
 
Max Bupa Health Assurance offers a combination of three health covers—PA, Critical Illness and Hospital Cash, with an option to choose all or any of the three covers. The product can be bought between 18-65 years; PA and Hospital Cash are offered to children from age 2-21 years. 
 
The premium for PA cover is same for ages 18-65 years. According to Sevantika Bhandari, Director-Marketing, “For customers above 65 years of age, the premium for PA cover will vary. We are offering PA, Critical Illness and Hospital Cash under Health Assurance with life-long renewal. In fact, we were the first in the industry to introduce the option of life-long renewal with the launch of our flagship product Heartbeat (Mediclaim) in 2010.” 
 
Here are the pros and cons:
 
Advantages – 
 
Reasonable premium at Rs780 for Rs5 lakh cover for ages 18-65 years. You can get PA policy in the range of Rs500 to Rs800 for same cover, but the Max Bupa product also covers child education benefit of 5% of the Sum Insured (SI) or Rs50,000 per child, whichever is lower and funeral expenses of Rs5,000 in case of accidental death
 
Maximum entry age is 65 years. Life-long renewal is a welcome step, but it does come at a little price. 
Health Assurance Personal Accident Benefit Table (inclusive of service tax of 12.36%)
 
Disadvantages – 
 
The product only covers accidental death, permanent total disability (PTD) and permanent partial disability (PPD). Temporary total disability (TTD) is a good optional feature available in many PA products, but is missing in the Max Bupa offering. TTD usually pays 1% of the SI for 100 weeks in case of disability preventing one from going to work
 
The list specified for PPD is not comprehensive. It does not cover for loss of fingers, smell, taste, and so on. A general statement like “any other permanent partial disability—percentage as assessed by the doctor”, which is present in many PA products would have helped
 
Critical Illness is a good product considering the following pros and cons:
 
Advantages – 
 
Lifelong renewal
 
20 critical illnesses like cancer, first heart attack, stroke, paralysis, major burns, coma, kidney failure, open chest coronary artery bypass surgery, etc are covered
 
Floater option is available for two adults
 
Very reasonable premium at Rs752, Rs2436, Rs13465 for Rs3 lakh cover (age 27, 42 and 65 respectively)
 
Pre-existing coverage offered after four years of continuous coverage. Most critical illness products do not cover pre-existing diseases
 
Disadvantages – 
 
90 days of waiting period and 30 days of survival period for the policy to pay. Some critical illness products in the market cover with zero survival period
 

 

User

COMMENTS

Harshit

3 years ago

Thanks for sharing. so what the lifelong assure by bajaj allianz, whats the difference between this

Harshit

3 years ago

thanks for sharing but what is life long assure by Bajaj Allianz.

FDA wants Gutka owners to pay for seized goods destruction

Maharashtra FDA has decided to recover or ask Gutkha manufacturers from whom the goods have been seized to incur expenses of destroying the stocks

Thane: Having seized banned Gutka of over Rs4 crore, the Food and Drug Administration (FDA), which is now faced with the uphill task of destroying the stock, lying at its office in Thane has decided to recover expenses in this regard from concerned parties, whose goods have been impounded, reports PTI.

 

The FDA office near ESIS Hospital premises in Wagle Industrial Estate has already become a virtual godown to all seized goods with no room to move around.

 

An FDA official, who is also in-charge of the drive carried out since last four months said that the Konkan division which has the distinction of topping the list of seizures in Maharashtra has a stock of around five tonnes of gutka.

 

He could not however classify the Gutka and supari-mix stock which the department has seized.

 

According to sources, the department will incur expenses of Rs26.50 per kg for the destruction of the seized Gutka.

 

Hence the destruction of the five tonnes of the seized Gutka will cost the department around Rs13.25 lakh. Add transportation cost to it and the expenditure will go high, they said.

 

According to officials, FDA has identified a facility at Devnar which is approved by the Maharashtra Pollution Control Board (MPCB) for destruction of the seized goods. But now it has decided to recover or ask the concerned parties from whom the goods have been seized to incur these expenses.

 

However, it is not clear whether the parties have agreed to take up these expenses.

 

Meanwhile the FDA has written to the civic corporations here seeking their nod to dispose of the seized goods in their dumping yard which needs to be done in the presence of senior FDA officials.

 

However none of the civic corporations have responded yet.

 

Moreover land fill is not permitted as Gutka plastic/polythene cover is a banned item for land fill and will give rise to environmental issues.

User

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)